ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ICAD Icade

28.24
0.00 (0.00%)
16 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Icade EU:ICAD Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 28.24 27.34 28.26 0.00 01:00:00

iCAD to Present at Canaccord Adams 27th Annual Global Growth Conference

25/07/2007 3:33pm

PR Newswire (US)


Icade (EU:ICAD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Icade Charts.
NASHUA, N.H., July 25 /PRNewswire-FirstCall/ -- iCAD, Inc. (NASDAQ:iCAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer of iCAD, will be presenting at the Canaccord Adams 27th Annual Global Growth Conference on Tuesday, August 7, 2007 at 11 a.m. (Eastern Daylight Time) at the Intercontinental Hotel in Boston. The presentation will be webcast live and archived for replay on the "Investors" section of the company's website at http://www.icadmed.com/. An audio webcast of the presentation will be available after the conference at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ICAD&item_id=1609758. About iCAD, Inc. iCAD, Inc. (NASDAQ:iCAD) is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com/. For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at For iCAD Investor Relations, contact Kevin McGrath of Cameron Associates at 212-245-4577 or via email at For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at DATASOURCE: iCAD, Inc. CONTACT: Darlene Deptula-Hicks of iCAD, EVP and CFO, +1-603-882-5200, ext. 7944, ; or Investors, Kevin McGrath of Cameron Associates, +1-212-245-4577, , for iCAD, Inc.; or Media, Wendy Ryan of Schwartz Communications, +1-781-684-0770, , for iCAD, Inc. Web site: http://www.icadmed.com/

Copyright

1 Year Icade Chart

1 Year Icade Chart

1 Month Icade Chart

1 Month Icade Chart

Your Recent History

Delayed Upgrade Clock